Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUOC-01 in Primary Progressive Multiple Sclerosis
NCT04943289Phase 1Completed
- Sponsor
- Joanne Kurtzberg
- Start
- Jan 2021
- Primary completion
- Sep 2025
- Modality
- CAR-Macrophages
- Countries
- 1
01
Overview
Phase 1, open-label trial of DUOC-01 in primary progressive multiple sclerosis (PPMS), sponsored by Joanne Kurtzberg. Primary endpoint: Incidence of intrathecal administration adverse events at 2 weeks. Started Jan 2021; status: completed.
02
Drugs
DUOC-01
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on NCT04943289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04943289.